Weight-loss jabs could halve risk of obesity-related cancers, study finds
Weight-loss jabs could almost halve the risk of obesity-related cancers, a landmark study suggests.
Cancer experts said the findings were 'transformational' and could herald a 'whole new era of preventive cancer medicine'.
Obesity is associated with 13 different cancers. While losing weight reduces that risk, scientists have calculated weight-loss injections have a bigger protective effect over and above shedding the kilos.
Researchers in Israel studied 6,000 adults with no prior history of cancer, who either underwent bariatric surgery or took glucagon-like peptide-1 receptor agonists (GLP-1RAs) liraglutide (Saxenda), exenatide (Byetta) or dulaglutide (Trulicity). The drugs work by mimicking the GLP-1 hormone in the body, which lowers blood sugar levels and makes people feel fuller for longer.
Although those who had bariatric surgery lost around double the weight of those on weight-loss medication, the study, presented at the European Congress on Obesity in Malaga, Spain, and published in The Lancet's eClinicalMedicine, found the reduction in cancer risk was broadly the same.
Bariatric surgery reduces the risk of cancer by 30-42%, the researchers said. Therefore, accounting for the relative advantage of surgery in reducing patients' weight, the authors found weight-loss drugs were more effective at preventing obesity-related cancer.
'The protective effects of GLP-1RAs against obesity-related cancers likely arise from multiple mechanisms, including reducing inflammation,' said co-lead author Prof Dror Dicker from Hasharon Hospital, Rabin Medical Center, Petah Tikva, Israel.
Newer drugs could prove even more beneficial, he added. 'New generation, highly potent GLP-1RAs with higher efficacy in weight reduction may convey an even greater advantage in reducing the risk of obesity-related cancers, but future research is needed to make sure these drugs do not increase the risk for non-obesity-related cancers.'
A separate study, presented at the conference and published in New England Journal of Medicine, directly compared weight-loss jabs and found patients taking Mounjaro lost about 50% more weight than those taking Wegovy. Patients on Mounjaro typically saw a 20.2% drop in body weight at the end of the trial compared with 13.7% with Wegovy.
Responding to the findings, Prof Mark Lawler, an internationally renowned cancer research expert from Queen's University Belfast, said while this was an observational study and caution was needed interpreting the results, the results were very exciting.
'We already know bariatric surgery cuts obesity-related cancer risk by about a third; these data suggest target GLP-1s may cut that risk by nearly 50% – an approach that would be transformational in preventing obesity-related cancer.
'Biologically, this makes sense, as targeting GLP-1 dampens down inflammation, one of the hallmarks of cancer.
'While further work is required on how it works, these data raise the intriguing possibility that a GLP-1 jab could prevent multiple cancers in the general population, including common cancers like breast and colorectal, and difficult to treat cancers like pancreatic and ovarian. This work could herald a whole new era of preventive cancer medicine.'
Prof Jason Halford, former president of the European Association for the Study of Obesity and head of psychology at Leeds University, said the drugs should also be tested in patients with newly diagnosed cancers to see if they boosted survival chances.
He added the drugs had 'the potential to be a new dawn. And it's not just prevention, weight management in people recently diagnosed with cancer is also critical in terms of outcomes. That would be the next thing to look at. More and more cancers are being associated with obesity.'
A team of 54 international experts from 12 different countries issued a joint statement at the conference, calling for weight-loss drugs to be trialled as a priority for cancer prevention. As a result, a UK team of scientists, based at the University of Manchester and funded by Cancer Research UK, are planning a large-scale clinical trial involving tens of thousands of patients, which they hope to get under way within 'three to five years'.
Dr Matthew Harris, at the Manchester Cancer Research Centre, said weight-loss jabs 'provide genuinely fantastic weight loss, and may provide an intervention that could be delivered on a population-scale, where we have not been able to achieve this before'.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Guardian
3 hours ago
- The Guardian
Israeli forces kill at least 60 Palestinians seeking food aid in Gaza, health officials say
Israeli forces killed at least 60 Palestinians in Gaza on Wednesday, most of them as they were seeking food from a US-Israeli distribution scheme, according to local health authorities. Medical officials said at least 25 people were killed and dozens wounded as they approached a food distribution centre run by the Gaza Humanitarian Foundation (GHF), near Netzarim in central Gaza. Later in the day, at least 14 people were killed by Israeli gunfire as they were moving towards another GHF distribution site, in Rafah, at Gaza's southern border. On Tuesday Israeli troops killed 17 Palestinians around GHF sites. The mass casualties came as the bodies of two Israel hostages were recovered from Gaza by the army and the internal security service, Shin Bet. Israeli prime minister, Benjamin Netanyahu, issued a statement naming one of the dead hostages as Yair Yaakov, a 59-year-old father of three who was abducted and killed by Hamas in its 7 October 2023 attack in which 1200 Israelis were killed and triggered the conflict. Netanyahu said the second hostage whose remains were recovered, could not yet be named. There are thought to be 53 Israelis hostages still in Gaza, but most of them are believed to be dead. The Gaza health authorities said on Wednesday the Palestinian death toll over the 20 months of conflict had passed 55,000. The health ministry was part of the Hamas government, but is staffed by medical professionals and its casualty statistics are generally regarded as reliable by the UN and other global organisations. In recent days, more and more of the fatalities have been associated with GHF food distribution. On Wednesday, a New York-based law group, the Center for Constitutional Rights, warned the GHF of its 'potential legal liability for complicity in Israel's war crimes, crimes against humanity, and genocide against Palestinians'. 'As Palestinians now face mass starvation, Israel has teamed up with GHF to make accessing food not only dangerous and potentially deadly but also a tool of forced displacement,' its senior staff attorney, Katherine Gallagher, said. 'If GHF continues its militarised aid operations, it must be prepared to face the legal consequences, whether in the United States or beyond.' The Israeli government and armed forces are now under scrutiny by the International Court of Justice, on allegations of genocide, in part because of the use of food as a weapon against the occupied territory's 2.2 million people. Humanitarian experts had previously warned that the GHF scheme or distributing food from a restricted number of heavily militarised sites would be highly dangerous for people seeking food, forcing them to cross combat zones. The organisation's first executive director, Jake Wood, resigned last month, saying its plan ran counter to 'humanitarian principles'. Last week, a US consulting firm, Boston Consulting Group which had helped set up the GHF, severed ties with the organisation. Johnnie Moore, an evangelical leader and religious adviser to Donald Trump, with a record of outspoken support for Israel and minimal experience of humanitarian work, was appointed the new chair of the GHF. The Israel Defense Forces (IDF) said that its forces had fired 'warning shots' overnight towards a group it said posed a threat to troops 'This is despite warnings that the area is an active combat zone. The IDF is aware of reports regarding individuals injured; the details are under review,' the IDF said. The GHF told the Reuters news agency it was unaware of Wednesday's incidents but added that it was working closely with Israeli authorities to ensure safe passage routes are maintained, and that it was essential for Palestinians to closely follow instructions. 'Ultimately, the solution is more aid, which will create more certainty and less urgency among the population,' it said. 'There is not yet enough food to feed everyone in need in Gaza. Our current focus is to feed as many people as is safely possible within the constraints of a highly volatile environment.' In a social media post on Wednesday, Moore said he had visited a GHF packing and distribution centre in Israel on Wednesday and claimed the organisation provided 2.5 million meals on Wednesday bringing to 16 million meals distributed in Gaza since it started operations on 27 May. Also on Wednesday, an Israeli civil rights group, Adalah, said that one of an international group of activists detained by Israel on a ship in the eastern Mediterranean, was being held in solitary confinement. In a statement it said that a Brazilian protester, Tiago Ávila, was being held in isolation in Ayalon prison 'due to his ongoing hunger and thirst strike, which he began two days ago'. Another activist detained on the Madleen protest ship, a French-Palestinian member of the European parliament, Rima Hassan, was temporarily held in solitary confinement, in Neve Tirza prison after writing 'Free Palestine' on a cell wall. 'She was moved to a small, windowless cell with extremely poor hygienic conditions and has been denied access to the prison yard,' Adalah said. It added that Hassan had been moved out of isolation on Wednesday. There was no immediate response from the Israeli foreign ministry to the reports of solitary confinement.
The Sun
7 hours ago
- The Sun
I went from 18st to 8.5st on Mounjaro, there's a dark side coming off no-one talks about – I've gone back on it 3 times
A WOMAN has shared how she lost a staggering 9.5 stone being on Mounjaro, but said there was a dark side that no one talks about when you come off. Shannon revealed she went from 18 stone to 8.5 stone on the popular weight loss jab, and she's been on it three times after 'failing' to ditch it. 4 On her @shanmacxo account, she insisted that it was 'genuinely the best thing I ever did for myself' and said 'it will change your life.' However, coming off the injections is extremely tough - and she claims she is now an 'addict' of its effects. In a video that has 85,000 views, she shared: 'I've been taking Mounjaro now for 16 months. I have gone from 18 stone, and I weigh 8 stone 5 now." She shared how she had come off the weight loss jab three times 'cold turkey' and each time has 'completely failed and got back on it.' Shannon said she'd been on a maintenance dose of 7.5 and had been injecting herself every week or every other week. But when it came to stopping, she faced a big obstacle. Shannon explained: 'The last week or so has been like I have been an addict. My brain has been like, I need it, I need to order it. 'I'm eating far too much. I've got this severe, sickening worry that I'm gonna put weight on, checking the scales all of the time.' Shannon said she thinks her issues come from her feeling like she was 'big' her whole life. She said that she's been really worried about putting on a single pound and caved about bought more of the weight loss jab, although the decision left her "disappointed in myself." RELIANT FOR LIFE? And it's not just her who finds the weight loss method 'addictive.' She explained: 'And friends do the same as well, where they've come off it, lost so much weight, and then they're just like, 'I need— I need it back.'' Due to her reliance on the controversial weight loss jab, she wondered if she will now be reliant on it 'for life'. She continued: 'Is it a life thing? It's not sustainable financially for life. 'I feel like this isn't talked about enough, and how we are supposed to manage the weight loss after— and the food noise—it's a real struggle." JAB WARNING Mounjaro (tirzepatide) - which can have negative side effects for some users - became available in the UK in February 2024, primarily for private use. But access to the weight loss jab through the NHS has gradually been rolled out. By activating GIP and GLP-1 receptors, Mounjaro slows down the emptying of the stomach, making you feel fuller for longer and reducing appetite. This can lead to eating less food overall. In addition to nasty side effects, those debating whether to begin using Mounjaro should know that it can also have fatal consequences. Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines. The injections are licensed for patients with type 2 diabetes and are administered every seven days. They are also available to assist those who are clinically obese (with a Body Mass Index of 30 or over). The drugs, which have been widely regarded as 'fat jabs', can be prescribed by a practitioner - such as a doctor, nurse or a pharmacist-independent prescriber. But increasingly, we are seeing more and more people buying them through online pharmacies, without sufficient checks. Not only this, but recently, figures from the Medicines and Healthcare products Regulatory Agency revealed that fat jabs had been linked to 82 deaths across the UK. 4
Daily Mail
9 hours ago
- Daily Mail
EXCLUSIVE Doctor issues urgent cancer warning over hidden chemical in drink you have EVERY DAY
A hidden chemical in coffee could be raising your risk of cancer, a top longevity doctor has warned. Acrylamide is not added to the beverage or listed on labels, but forms at high temperatures during the roasting process. Your browser does not support iframes.
